Lobbying activity

Q2

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q2

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $220,000.00 income

Copyright/Patent/Trademark, Health Issues

View → Q2

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q2

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q2

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

AARP for AARP

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Pharmacy, Family issues/Abortion/Adoption

View → Q2

TODD STRATEGY GROUP for NOVARTIS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Tariff (miscellaneous tariff bills), Health Issues

View → Q2

BIOGEN for BIOGEN

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q2

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark

View → Q2

LUNDBECK LLC for LUNDBECK LLC

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q2

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate

Taxation/Internal Revenue Code, Veterans, Tariff (miscellaneous tariff bills), Medicare/Medicaid

View → Q2

DLA PIPER LLP (US) for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → Q2

FAMILIES USA FOUNDATION, INC. for FAMILIES USA FOUNDATION INC

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy

View → Q2

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income

Health Issues

View → Q2

DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy

View → Q2

PRIME THERAPEUTICS for PRIME THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q2

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q2

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $30,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

HORIZON GOVERNMENT AFFAIRS for PHRMA

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues

View → Q2

ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS

2nd Quarter (Apr 1 - June 30) 2025 · South Carolina · House · Senate · $15,000.00 income

Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code

View → 1A

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View → Q1

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign), Defense

View → Q1

EMD SERONO, INC. for EMD SERONO INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Science/Technology, Trade (domestic/foreign), Health Issues, Medicare/Medicaid

View → Q1

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations

View →